|
|
|
| The Value of Tissue Banks |
||
| to Drug and Dx Developers |
||
|
|
|
|
|
|
| Barbara
L. Handelin, Ph.D. |
|||||
| Conflicts
of Interest, Privacy/Confidentiality, |
|||||
| and
Tissue Repositories: |
|||||
| Protections,
Policies, and Practical Strategies |
|||||